Chronic activation of AMP-activated protein kinase leads to early-onset polycystic kidney phenotype
出版年份 2021 全文链接
标题
Chronic activation of AMP-activated protein kinase leads to early-onset polycystic kidney phenotype
作者
关键词
-
出版物
CLINICAL SCIENCE
Volume 135, Issue 20, Pages 2393-2408
出版商
Portland Press Ltd.
发表日期
2021-10-08
DOI
10.1042/cs20210821
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- A substrate-specific mTORC1 pathway underlies Birt–Hogg–Dubé syndrome
- (2020) Gennaro Napolitano et al. NATURE
- Metformin effectively treats Tsc1 deletion-caused kidney pathology by upregulating AMPK phosphorylation
- (2020) Yili Fang et al. Cell Death Discovery
- The Transcription Factors TFEB and TFE3 Link the FLCN-AMPK Signaling Axis to Innate Immune Response and Pathogen Resistance
- (2019) Leeanna El-Houjeiri et al. Cell Reports
- AMP-activated protein kinase: the current landscape for drug development
- (2019) Gregory R. Steinberg et al. NATURE REVIEWS DRUG DISCOVERY
- PAN-AMPK ACTIVATION IMPROVES RENAL FUNCTION IN A RAT MODEL OF PROGRESSIVE DIABETIC NEPHROPATHY
- (2019) Xiaoyan Zhou et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- AMPK promotes induction of the tumor suppressor FLCN through activation of TFEB independently of mTOR
- (2019) Caterina Collodet et al. FASEB JOURNAL
- The pathobiology of polycystic kidney disease from a metabolic viewpoint
- (2019) Luis Fernando Menezes et al. Nature Reviews Nephrology
- Salsalate, but not metformin or canagliflozin, slows kidney cyst growth in an adult-onset mouse model of polycystic kidney disease
- (2019) Wouter N. Leonhard et al. EBioMedicine
- A Randomized Clinical Trial of Metformin to Treat Autosomal Dominant Polycystic Kidney Disease
- (2018) Stephen L. Seliger et al. AMERICAN JOURNAL OF NEPHROLOGY
- Polycystic kidney features of the renal pathology in glycogen storage disease type I: possible evolution to renal neoplasia
- (2018) Monika Gjorgjieva et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Phosphorylation of Acetyl-CoA Carboxylase by AMPK Reduces Renal Fibrosis and Is Essential for the Anti-Fibrotic Effect of Metformin
- (2018) Mardiana Lee et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Metabolism and mitochondria in polycystic kidney disease research and therapy
- (2018) Valeria Padovano et al. Nature Reviews Nephrology
- Selective Activation of AMPK β 1-Containing Isoforms Improves Kidney Function in a Rat Model of Diabetic Nephropathy
- (2017) Christopher T. Salatto et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Mitochondrial Abnormality Facilitates Cyst Formation in Autosomal Dominant Polycystic Kidney Disease
- (2017) Yu Ishimoto et al. MOLECULAR AND CELLULAR BIOLOGY
- microRNA-17 family promotes polycystic kidney disease progression through modulation of mitochondrial metabolism
- (2017) Sachin Hajarnis et al. Nature Communications
- Liver-Specific Activation of AMPK Prevents Steatosis on a High-Fructose Diet
- (2017) Angela Woods et al. Cell Reports
- Metformin Inhibits Cyst Formation in a Zebrafish Model of Polycystin-2 Deficiency
- (2017) Ming-Yang Chang et al. Scientific Reports
- Chronic Activation of γ2 AMPK Induces Obesity and Reduces β Cell Function
- (2016) Arash Yavari et al. Cell Metabolism
- AMPK governs lineage specification through Tfeb-dependent regulation of lysosomes
- (2016) Nathan P. Young et al. GENES & DEVELOPMENT
- Progressive development of renal cysts in glycogen storage disease type I
- (2016) Monika Gjorgjieva et al. HUMAN MOLECULAR GENETICS
- Physiological Expression ofAMPKγ2RGMutation Causes Wolff-Parkinson-White Syndrome and Induces Kidney Injury in Mice
- (2016) Xiaodong Yang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Modelling TFE renal cell carcinoma in mice reveals a critical role of WNT signaling
- (2016) Alessia Calcagnì et al. eLife
- Fatty Acid Oxidation is Impaired in An Orthologous Mouse Model of Autosomal Dominant Polycystic Kidney Disease
- (2016) Luis F. Menezes et al. EBioMedicine
- Inhibition of Aerobic Glycolysis Attenuates Disease Progression in Polycystic Kidney Disease
- (2016) Meliana Riwanto et al. PLoS One
- 2-Deoxy-D-Glucose Ameliorates PKD Progression
- (2015) M. Chiaravalli et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Food Restriction Ameliorates the Development of Polycystic Kidney Disease
- (2015) G. Warner et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The Nutrient-Responsive Transcription Factor TFE3 Promotes Autophagy, Lysosomal Biogenesis, and Clearance of Cellular Debris
- (2014) J. A. Martina et al. Science Signaling
- Pompe disease: from pathophysiology to therapy and back again
- (2014) Jeong-A Lim et al. Frontiers in Aging Neuroscience
- Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP
- (2013) Russell A. Miller et al. NATURE
- Metabolic reprogramming in polycystic kidney disease
- (2013) Carmen Priolo et al. NATURE MEDICINE
- Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy
- (2013) Isaline Rowe et al. NATURE MEDICINE
- Polycystic Kidney Disease: A Case of Suppressed Autophagy?
- (2013) Kameswaran Ravichandran et al. SEMINARS IN NEPHROLOGY
- The Transcription Factor TFEB Links mTORC1 Signaling to Transcriptional Control of Lysosome Homeostasis
- (2012) A. Roczniak-Ferguson et al. Science Signaling
- Molecular Mechanism by Which AMP-Activated Protein Kinase Activation Promotes Glycogen Accumulation in Muscle
- (2011) Roger W. Hunter et al. DIABETES
- Hexokinase: a novel sugar kinase coupled to renal epithelial cell survival
- (2011) R. Brooks Robey KIDNEY INTERNATIONAL
- Hexokinase regulates Bax-mediated mitochondrial membrane injury following ischemic stress
- (2011) Jonathan M. Gall et al. KIDNEY INTERNATIONAL
- Activating AMP-activated protein kinase (AMPK) slows renal cystogenesis
- (2011) V. Takiar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TFEB Links Autophagy to Lysosomal Biogenesis
- (2011) C. Settembre et al. SCIENCE
- Cyclic AMP-mediated cyst expansion
- (2010) Darren P. Wallace BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Inactivation of the FLCN Tumor Suppressor Gene Induces TFE3 Transcriptional Activity by Increasing Its Nuclear Localization
- (2010) Seung-Beom Hong et al. PLoS One
- AMP-activated protein kinase phosphorylation of the R domain inhibits PKA stimulation of CFTR
- (2009) J Darwin King et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- AMPK controls epithelial Na+ channels through Nedd4-2 and causes an epithelial phenotype when mutated
- (2009) Joana Almaça et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- A Gene Network Regulating Lysosomal Biogenesis and Function
- (2009) Marco Sardiello et al. SCIENCE
- Cyst formation and activation of the extracellular regulated kinase pathway after kidney specific inactivation of Pkd1
- (2008) Sekiya Shibazaki et al. HUMAN MOLECULAR GENETICS
- Kidney-Targeted Birt-Hogg-Dube Gene Inactivation in a Mouse Model: Erk1/2 and Akt-mTOR Activation, Cell Hyperproliferation, and Polycystic Kidneys
- (2008) M. Baba et al. JNCI-Journal of the National Cancer Institute
- A mouse model for polycystic kidney disease through a somatic in-frame deletion in the 5′ end of Pkd1
- (2008) P.G. Starremans et al. KIDNEY INTERNATIONAL
- AMPK Phosphorylation of Raptor Mediates a Metabolic Checkpoint
- (2008) Dana M. Gwinn et al. MOLECULAR CELL
- Regulation of Cl− secretion by AMPK in vivo
- (2008) Patthara Kongsuphol et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Deficiency of FLCN in Mouse Kidney Led to Development of Polycystic Kidneys and Renal Neoplasia
- (2008) Jindong Chen et al. PLoS One
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now